ORIONINFU Stock Overview
Manufactures and sells large volume parenteral and other lifesaving injectable products in Bangladesh. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Orion Infusion Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳397.80 |
| 52 Week High | ৳726.90 |
| 52 Week Low | ৳217.20 |
| Beta | -1.74 |
| 1 Month Change | 26.09% |
| 3 Month Change | 6.85% |
| 1 Year Change | -3.73% |
| 3 Year Change | 345.96% |
| 5 Year Change | 642.16% |
| Change since IPO | 3,215.01% |
Recent News & Updates
Recent updates
Shareholder Returns
| ORIONINFU | BD Pharmaceuticals | BD Market | |
|---|---|---|---|
| 7D | 24.2% | 5.0% | 2.1% |
| 1Y | -3.7% | -24.3% | -21.0% |
Return vs Industry: ORIONINFU exceeded the BD Pharmaceuticals industry which returned -24.3% over the past year.
Return vs Market: ORIONINFU exceeded the BD Market which returned -21% over the past year.
Price Volatility
| ORIONINFU volatility | |
|---|---|
| ORIONINFU Average Weekly Movement | 11.6% |
| Pharmaceuticals Industry Average Movement | 7.6% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in BD Market | 9.0% |
| 10% least volatile stocks in BD Market | 3.5% |
Stable Share Price: ORIONINFU's share price has been volatile over the past 3 months compared to the BD market.
Volatility Over Time: ORIONINFU's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of BD stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 718 | Salman Karim | www.orioninfusion.com |
Orion Infusion Limited manufactures and sells large volume parenteral and other lifesaving injectable products in Bangladesh. The company offers I.V. rehydration, electrolyte, and acidosis solutions; ranitidine I.V. infusion; anti-microbial products; metronidazole I.V; pure steam generated fluids; and amino acids solution. The company was formerly known as Mala Chemical & Pharmaceuticals Industries Ltd.
Orion Infusion Limited Fundamentals Summary
| ORIONINFU fundamental statistics | |
|---|---|
| Market cap | ৳8.10b |
| Earnings (TTM) | ৳39.97m |
| Revenue (TTM) | ৳790.20m |
202.6x
P/E Ratio10.2x
P/S RatioIs ORIONINFU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ORIONINFU income statement (TTM) | |
|---|---|
| Revenue | ৳790.20m |
| Cost of Revenue | ৳466.52m |
| Gross Profit | ৳323.69m |
| Other Expenses | ৳283.72m |
| Earnings | ৳39.97m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.96 |
| Gross Margin | 40.96% |
| Net Profit Margin | 5.06% |
| Debt/Equity Ratio | 93.4% |
How did ORIONINFU perform over the long term?
See historical performance and comparisonDividends
0.3%
Current Dividend Yield61%
Payout RatioDoes ORIONINFU pay a reliable dividends?
See ORIONINFU dividend history and benchmarks| Orion Infusion dividend dates | |
|---|---|
| Ex Dividend Date | Dec 05 2024 |
| Dividend Pay Date | Jan 26 2025 |
| Days until Ex dividend | 17 days |
| Days until Dividend pay date | 35 days |
Does ORIONINFU pay a reliable dividends?
See ORIONINFU dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 07:27 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Orion Infusion Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|